Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ove Juul Nielsen

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|December 4, 2009
[Thrombotic microangiopathies]Ove Juul Nielsen, Lennart Friis-Hansen
Cancer Causes & Control : CCC|August 13, 2009
Trends in adult leukemia incidence and survival in Denmark, 1943-2003Lau Caspar Thygesen, Ove Juul Nielsen, Christoffer Johansen
Cold Spring Harbor Molecular Case Studies|August 24, 2016
Whole-exome sequencing of a patient with severe and complex hemostatic abnormalities reveals a possible contributing frameshift mutation in C3AR1Eva Leinøe, Ove Juul Nielsen, Lars Jønson, et al.
Danish Medical Journal|March 3, 2012
Intensive care of haematological patientsTobias Magid, Nicolai Haase, Jakob Steen Andersen, et al.
European Journal of Haematology|December 17, 2009
Safe and feasible outpatient treatment following induction and consolidation chemotherapy for patients with acute leukaemiaTom Møller, Ove Juul Nielsen, Pernille Welinder, et al.
European Journal of Haematology|September 17, 2013
Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 geneCecilie Utke Rank, Johanna Kremer Hovinga, Magnus Mansouri Taleghani, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2012
Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemiaMikkel Krogh-Madsen, Brendan Bender, Morten Krogh Jensen, et al.
Ugeskrift for Laeger|January 26, 2011
[New treatment options for primary immune thrombocytopenia]Sif Gudbrandsdottir, Henrik Frederiksen, Henrik Sverre Birgens, et al.
Ugeskrift for Laeger|January 26, 2011
[The pathogenesis of primary immune thrombocytopenia]Sif Gudbrandsdottir, Henrik Frederiksen, Henrik Sverre Birgens, et al.
Ugeskrift for Laeger|July 11, 2006
[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?]Henrik Schrøder, Marthe Kjeldstad, Anne Marie Boesen, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|December 4, 2009
[Thrombotic microangiopathies]Ove Juul Nielsen, Lennart Friis-Hansen
Cancer Causes & Control : CCC|August 13, 2009
Trends in adult leukemia incidence and survival in Denmark, 1943-2003Lau Caspar Thygesen, Ove Juul Nielsen, Christoffer Johansen
Cold Spring Harbor Molecular Case Studies|August 24, 2016
Whole-exome sequencing of a patient with severe and complex hemostatic abnormalities reveals a possible contributing frameshift mutation in C3AR1Eva Leinøe, Ove Juul Nielsen, Lars Jønson, et al.
Danish Medical Journal|March 3, 2012
Intensive care of haematological patientsTobias Magid, Nicolai Haase, Jakob Steen Andersen, et al.
European Journal of Haematology|December 17, 2009
Safe and feasible outpatient treatment following induction and consolidation chemotherapy for patients with acute leukaemiaTom Møller, Ove Juul Nielsen, Pernille Welinder, et al.
European Journal of Haematology|September 17, 2013
Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 geneCecilie Utke Rank, Johanna Kremer Hovinga, Magnus Mansouri Taleghani, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2012
Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemiaMikkel Krogh-Madsen, Brendan Bender, Morten Krogh Jensen, et al.
Ugeskrift for Laeger|January 26, 2011
[New treatment options for primary immune thrombocytopenia]Sif Gudbrandsdottir, Henrik Frederiksen, Henrik Sverre Birgens, et al.
Ugeskrift for Laeger|January 26, 2011
[The pathogenesis of primary immune thrombocytopenia]Sif Gudbrandsdottir, Henrik Frederiksen, Henrik Sverre Birgens, et al.
Ugeskrift for Laeger|July 11, 2006
[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?]Henrik Schrøder, Marthe Kjeldstad, Anne Marie Boesen, et al.
Pageof 3